Seelos Therapeutics
SEEL
#10517
Rank
NZ$0.36 M
Marketcap
NZ$0.63
Share price
-31.49%
Change (1 day)
-98.17%
Change (1 year)

Earnings for Seelos Therapeutics (SEEL)

Earnings in 2024 (TTM): NZ$7.41 Million

According to Seelos Therapeutics 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -NZ$63.93 Million, an increase over its 2022 earnings that were of -NZ$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seelos Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$7.41 M-111.61%
2023 -NZ$63.93 Million-48.58%
2022 -NZ$0.13 Billion14.07%
2021 -NZ$0.11 Billion240.34%
2020 -NZ$32.02 Million-62.76%
2019 -NZ$85.98 Million587.73%
2018 -NZ$12.51 Million-36.54%
2017 -NZ$19.7 Million74.83%
2016 -NZ$11.27 Million-63.26%
2015 -NZ$30.68 Million-18.06%
2014 -NZ$37.44 Million46.19%
2013 -NZ$25.61 Million-31.67%
2012 -NZ$37.48 Million
2010 -NZ$35.11 Million448.63%
2009 -NZ$6.4 Million-25.83%
2008 -NZ$8.63 Million-45.65%
2007 -NZ$15.88 Million2.82%
2006 -NZ$15.44 Million-41.86%
2005 -NZ$26.55 Million-9.27%
2004 -NZ$29.26 Million114.92%
2003 -NZ$13.62 Million-70.78%
2002 -NZ$46.6 Million60.2%
2001 -NZ$29.09 Million70.3%
2000 -NZ$17.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.26 Billion-3,626.04%๐Ÿ‡บ๐Ÿ‡ธ USA